Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! By
Identification of Novel Drug Targets for Helicobacter Pylori: Structure-Based Virtual Screening of Potential Inhibitors Against Dah7ps Protein Involved in the Shikimate Pathway Publisher



N Noori Goodarzi NARJES ; M Khazani Asforooshani MAHSHID ; B Shahbazi BEHZAD ; N Rezaie Rahimi NAYEREH ; F Badmasti FARZAD
Authors

Source: Frontiers in Bioinformatics Published:2024


Abstract

Background: Helicobacter pylori, a bacterium associated with severe gastrointestinal diseases and malignancies, poses a significant challenge because of its increasing antibiotic resistance rates. This study aimed to identify potential drug targets and inhibitors against H. pylori using a structure-based virtual screening (SBVS) approach. Methods: Core-proteome analysis of 132 H. pylori genomes was performed using the EDGAR database. Essential genes were identified and human and gut microbiota homolog proteins were excluded. The DAH7PS protein involved in the shikimate pathway was selected for the structure-based virtual screening (SBVS) approach. The tertiary structure of the protein was predicted through homology modeling (based on PDB ID: 5UXM). Molecular docking was performed to identify potential inhibitors of DAH7PS among StreptomeDB compounds using the AutoDock Vina tool. Molecular dynamics (MD) simulations assessed the stability of DAH7PS-ligand complexes. The complexes were further evaluated in terms of their binding affinity, Lipinski’s Rule of Five, and ADMET properties. Results: A total of 54 novel drug targets with desirable properties were identified. DAH7PS was selected for further investigation, and virtual screening of StreptomeDB compounds yielded 36 high-affinity binding of the ligands. Two small molecules, 6,8-Dihydroxyisocoumarin-3-carboxylic acid and Epicatechin, also showed favorable RO5 and ADMET properties. MD simulations confirmed the stability and reliability of DAH7PS-ligand complexes, indicating their potential as inhibitors. Conclusion: This study identified 54 novel drug targets against H. pylori. The DAH7PS protein as a promising drug target was evaluated using a computer-aided drug design. 6,8-Dihydroxyisocoumarin-3-carboxylic acid and Epicatechin demonstrated desirable properties and stable interactions, highlighting their potential to inhibit DAH7PS as an essential protein. Undoubtedly, more experimental validations are needed to advance these findings into practical therapies for treating drug-resistant H. pylori. © 2024 Elsevier B.V., All rights reserved.
Related Docs
View other Related Docs
1. Clodronic Acid Has Strong Inhibitory Interactions With the Urease Enzyme of Helicobacter Pylori: Computer-Aided Design and in Vitro Confirmation, Current Computer-Aided Drug Design (2024)
2. Repurposing of Compounds From Streptomyces Spp. As Potential Inhibitors of Aminoacyltransferase Fema: An Essential Drug Target Against Antibiotic-Resistant Staphylococcus Aureus, Current Computer-Aided Drug Design (2025)
3. Helicobacter Pylori Strains From Duodenal Ulcer Patients Exhibit Mixed Baba/B Genotypes With Low Levels of Baba Adhesin and Lewis B Binding, Digestive Diseases and Sciences (2016)
Experts (# of related papers)
View all Related Experts
Habibollah Mahmoodzadeh (2)
Abbas Bahador (1)
Other Related Docs
4. Identification of Putative Drug Targets in Highly Resistant Gram-Negative Bacteria; and Drug Discovery Against Glycyl-Trna Synthetase As a New Target, Bioinformatics and Biology Insights (2023)
5. The Penicillin Binding Protein 1A of Helicobacter Pylori, Its Amoxicillin Binding Site and Access Routes, Gut Pathogens (2021)
6. In Silico Analysis of Penicillin- Binding Protein 5 As an Inhibitory Target of Beta-Lactam Antibiotics in Enterococcus Faecalis, Der Pharma Chemica (2015)
7. Molecular Docking of the Pneumococcal Main Autolysin (Lyta) and Deoxycholate Ligand, Pakistan Journal of Pharmaceutical Sciences (2020)
8. The Potential Use of Antibiotics Against Helicobacter Pylori Infection: Biopharmaceutical Implications, Frontiers in Pharmacology (2022)
9. Introduction of Novel Drug Targets Against Staphylococcus Aureus and Proposing Putative Inhibitors Against Adenine N1 (M1 A22)-Trna Methyltransferase (Trmk) Using Computer-Aided Drug Discovery, Current Pharmaceutical Design (2023)
10. Investigation of Molecular Mechanisms of S-1, Docetaxel and Cisplatin in Gastric Cancer With a History of Helicobacter Pylori Infection, Molecular Biotechnology (2024)
11. Medicinal Plants in the Treatment of Helicobacter Pylori Infections, Pharmaceutical Biology (2015)
12. A Systematic Review on Popularity, Application and Characteristics of Protein Secondary Structure Prediction Tools, Current Drug Discovery Technologies (2019)
13. The Outward Shift of Clarithromycin Binding to the Ribosome in Mutant Helicobacter Pylori Strains, Helicobacter (2020)
14. The Prevalence of Helicobacter Pylori Virulence Related Genes (Hpa and Baba2) in Iranian Patients With Gastrointestinal Disorders, Jundishapur Journal of Microbiology (2017)